Angel Broking is bullish on Cipla and has recommended buy rating on the stock with a target of Rs 369 in its August 05, 2011 research report.
"Cipla's numbers came in below our expectations on the top-line and bottom-line fronts for 1QFY2012, despite better-than-expected performance on the gross operating profit front. For FY2012, management has guided for 10-12% top-line growth. For 1QFY2012, Cipla reported net sales of Rs 1,550cr (Rs 1,427cr), 8.6% yoy growth and below our estimates of Rs 1,649cr. Gross margin expanded by 390bp yoy to 56.9% (53.0%). This was mainly on account of better product mix, which had lower proportion of anti-retrovirals in formulation exports. However, despite such gross margin expansion, OPM was flat at 21.2% (20.8%), led by increased manpower cost and negative contribution of Indore SEZ, as it is in the optimisation phase. Overall, other operating income reported a drop of 21.6% yoy to Rs 41.4cr (Rs 52.4cr) in 1QFY2012. Furthermore, adjusted net profit came in at Rs 253.4cr (Rs 257.4cr), a dip of 1.6% yoy, lower than our estimates due to higher interest costs during the quarter."
"We have revised our estimates and expect net sales to post a 15.5% CAGR to Rs 8,164cr and EPS to record a 23.8% CAGR to Rs 18.4 over FY2011-13E. The stock is trading at 20.7x and 16.7x FY2012E and FY2013E earnings, respectively. We recommend Buy on the stock with a revised target price of Rs 369," says Angel Broking research report.
Disclaimer:The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.